Exim Routes MD, chairman and AGM

Exim Routes board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Statutory auditor

Named in the results for the quarter to Mar 2026.

NKSC & Co.Peer-review certificate valid to Jul 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Exim Routes AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Exim Routes share news and announcements

Annual general meeting, 30 Sep 2026

538 shareholders on the register on 23 Sep 2026; present: 4 promoters and 9 others; votes counted by SHUBHAM RANJAN SINHA / SHUBHAM SINHA & ASSOCIATES.The company's voting result (opens in a new tab)

To receive Consider and Adopt the Audited Financial Statements of the Company for The Financial Year Ended On March 31, 2026 And Reports of Board of Directors and Auditors Thereon.
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 58.46% · promoters 99.77% · other public 12.18%
To Re-Appoint Mr. Manish Goyal (Din: 08126341), Who Retires by Rotation and Being Eligible, Offer Himself for Re-Appointment.
OrdinaryPromoters have an interest in it
100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 11.70% · promoters 11.27% · other public 12.18%
To consider and approve the appointment of Shubham Sinha & Associates as Secretarial Auditor of the company for 5 years from the financial year 2026-27 to 2030-31.
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 58.46% · promoters 99.77% · other public 12.18%
To consider and approve the additional disclosures pursuant to Regulation 6(2) read with Part C of Schedule I of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 in respect of the Exim Routes ESOP Plan 2025 and to address the observation/query raised by the National Stock Exchange of India Limited (“NSE”).MoreLess
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 58.46% · promoters 99.77% · other public 12.18%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Extraordinary general meeting, 13 Jul 2026, 4 resolutions

499 shareholders on the register on 6 Jul 2026; present: 2 promoters and 7 others; votes counted by SHUBHAM RANJAN SINHA / SHUBHAM SINHA & ASSOCIATES.The company's voting result (opens in a new tab)

To Consider and approve the Appointment of Mr. Shubham Khandelia (DIN: 10854834) as an Independent Director of the Company.
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 60.47% · promoters 99.63% · institutions 0.00% · other public 17.90%
To consider and approve the Ratification of the Pre – IPO ESOP Scheme (Exim Routes ESOP Plan 2025).
Special
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 60.47% · promoters 99.63% · institutions 0.00% · other public 17.90%
To Consider and Approve the Modification of Exim Routes ESOP Plan 2025 by Increase in the Employee Stock Option Pool from 5,51,296 Options to 15,00,000 Options
Special
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 60.47% · promoters 99.63% · institutions 0.00% · other public 17.90%
To consider and approve Grant of options to employee of subsidiary under the “Exim Routes ESOP Plan 2025"
Special
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 60.47% · promoters 99.63% · institutions 0.00% · other public 17.90%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Dealings with its subsidiaries, promoters, directors and their firms, reported every half-year.Promoters and their stake

Half-year to Mar 2026: ₹90.1 Cr23 dealings
Half-year to Sep 2025: ₹40.2 Cr25 dealings, 25 loans and advances

Between	Dealing
Exim Routes Limited and Exim Routes Pte Ltd, SingaporeExim Routes subsidiary	Advance	50.52	3.19	2.46
Exim Routes Limited and Manish GoyalPromotor/ Director of Exim Routes Limited	Any other transactionShort Term Borrowing (Given by Manish)	21.74	0.00	2.51
Exim Routes Limited and Exim Routes INC , USAExim Routes subsidiary	Purchase of goods or services	5.51	0.96	2.56
Exim Routes Limited and Exim Routes Pte Ltd, SingaporeExim Routes subsidiary	Sale of goods or services	3.32	0.82	1.52
Exim Routes Limited and Good Earth SCM GMBH, GermanyExim Routes subsidiary	Sale of goods or services	2.32	1.20	0.22
Exim Routes Limited and Exim Routes Pte Ltd, SingaporeExim Routes subsidiary	Investment	2.00	0.41	2.40
Exim Routes Limited and Exim Routes UK Ltd, UKExim Routes subsidiary	Sale of goods or services	1.36	0.33	0.19
Exim Routes Limited and Scan4Health Diagnosis Pvt LtdGroup company (Majority owner and Director is Dr. Charu Goyal - Manish Goyal's wife)	Loan	0.90	0.56	0.00
Exim Routes Limited and Exim Routes INC , USAExim Routes subsidiary	Sale of goods or services	0.83	0.43	0.12
Exim Routes Limited and Pallav SingalDirector, Exim Routes	Remuneration	0.33	0.00	0.02
Exim Routes Limited and Manish GoyalPromotor/ Director of Exim Routes Limited	Any other transactionOther Receivables	0.27	0.27	0.00
Exim Routes Limited and Govind Rai GargPromotor of Exim Routes Limited	Any other transactionOther Receivables	0.25	0.25	0.00
Exim Routes Limited and Manish GoyalPromotor/ Director of Exim Routes Limited	Remuneration	0.19	0.00	0.02
Exim Routes Limited and Vivinprasath DevarajDirector, Exim Routes	Remuneration	0.19	0.00	0.02
Exim Routes Limited and Govind Rai GargPromotor of Exim Routes Limited	Remuneration	0.16	0.00	0.00
Exim Routes Limited and Richa AnandCompany Secretary, Exim Routes	Remuneration	0.10	₹10,000	₹37,000
Exim Routes Limited and Vijay Kumar RathiDirector (now posthumous)	Remuneration	0.05	0.00	0.00
Exim Routes Limited and Anshul BansalCFO (India) Director, Exim Routes UK Lt	Remuneration	0.05	0.00	0.05
Exim Routes Limited and Exim Routes INC , USAExim Routes subsidiary	Investment	0.00	0.08	0.08
Exim Routes Limited and Exim Routes SA PTY Ltd, South AfricaExim Routes subsidiary	Any other transactionPayables for investment	0.00	0.05	0.05
Exim Routes Limited and Exim Routes UK Ltd, UKExim Routes subsidiary	Investment	0.00	0.10	0.10
Exim Routes Limited and Exim Routes SA PTY Ltd, South AfricaExim Routes subsidiary	Investment	0.00	0.05	0.05
Exim Routes Limited and Good Earth SCM GMBH, GermanyExim Routes subsidiary	Investment	0.00	0.16	0.16

The 23 largest of 23 dealings in the half-year to Mar 2026, ₹ crore.

Fines

Reported in the filing for the quarter to Jun 2026.

Fine or penaltyStock Exchange — National Stock Exchange of India Limited (NSE)Since 15 Jun 2026
Imposition of fine of Rs.10,000(Rupees Ten Thousand Only) plus GST levied by NSE and for alleged Non compliance with requirements of Regulation of 29(2) and 29(3) of the listing Regulation for the year ended 31st March 2026.
The fine has been imposed on account of alleged delay in furnishing prior intimation about the meeting of the board of directors.

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

Received
Resolved

Open at the quarter's end

None open at any quarter's end.

The filing has a part on fines and penalties: Yes
The filing has a part on tax disputes: No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Mar 2026.

Raised	Amount raised	For	Set aside	Spent	Spent elsewhere	Spent elsewhere, amount
Dec 2025, checked by CARE Rating Limited	43.73	Development and Maintenance of the ERIS platform	14.50	0.64	No	13.86
Dec 2025, checked by CARE Rating Limited	43.73	Working Capital Requirements	9.00	9.00	No
Dec 2025, checked by CARE Rating Limited	43.73	Investment in Office space to accommodate new hires	7.13	6.07	No	1.06
Dec 2025, checked by CARE Rating Limited	43.73	General Corporate Purpose	6.54	6.54	No	0.01
Dec 2025, checked by CARE Rating Limited	43.73	Issue Related Expenses	6.66	6.66	No	0.00

₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.